Diego Toesca, MD

Radiation Oncologist at @MayoClinic AZ | Opinions are my own

[Diego Toesca, MD @DiegoToesca]

@giuliani_luiza Parabéns Luiza!!! 🎉🎉🎉

[Michael Yan, MD MPH @MichaelYanMD]

Great day for HCC, with two very important rad onc trials to improve care for these patients.
@RadMedPM @pmcancercentre @BCLC_group @ldawsonmd @UofTDRO @thePMCF @UHN_Research

[Diego Toesca, MD @DiegoToesca]

@giuliani_luiza @AAWR_org Congratulations, Luiza!!! 👏👏👏👏

[Diego Toesca, MD @DiegoToesca]

Congrats Dr Sujay Vora and team!

https://t.co/c3RnSnbb9X

[Advances, an ASTRO Journal @Advances_ASTRO]

🔥Scanning Proton Arc Therapy (SPArc) SFRT!🔥

In-silico study shows that SPArc, when compared with VMAT or IMPT, is associated with:

✅Steeper high dose gradients
⬇️Gradient indices
✅Faster treatment time

🔎TBL: SPArc dosimetry may theoretically enhance the effects of SFRT

[Nirmal Raut @oncologician]

#ESMO2024 Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial by Alessio Amatu
- 97% dfs , 85% organ preservation achieved

[Mayo Clinic Arizona Radiation Oncology @MayoAZRadOnc]

Next week we will be hosting a virtual meet and greet for future radiation oncology residents: come learn more about our residency program!! #radonc

[Krishan Jethwa @KrishanJethwa]

🚨🚨RTOG 0848🚨🚨

Anatomically resectable PDAC randomized postoperatively
1st randomization:

Gemcitabine +/- erlotinib (no benefit with erlotinib)

🔥2nd Randomization🔥
+/- Chemoradiation, 50.4 Gy/28 fx + cape

✅⬆️ DFS w/ ☢️
✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️
#asco24

[Mayo Clinic Arizona Radiation Oncology @MayoAZRadOnc]

Huge congratulations to Dr. Jonathan Ashman who was awarded the Program Director of the Year Award at Mayo Clinic Arizona! We appreciate your commitment to our residency program and education shield of Mayo Clinic!

[Join Y. Luh, MD (he/him/dude/他) @j_luh]

Congratulations to #radonc travel grant recipients at @ACRCARROS1986 caucus at #ACR2024

#carros #radoncres @AmulyaYala

[Brady Laughlin, MD @BradyationOnc]

MC1635 is out in the Red Journal now as pre press! Thankful to the MCA team for getting this through. Check here: https://t.co/NEcneQIijb

[RSNATrainees @RSNATrainees]

Next up is our Publications SC! This fiery team educates trainees on all things research and publishing - from finding a mentor to creating illustrations! They also partner with our MS members to create the “Study of the Month” feature in the @RSNA R3 newsletter. You guys rock!

[Diego Toesca, MD @DiegoToesca]

@BradyationOnc @AnnieSadostyMD @AaronBushMD Congrats @BradyationOnc It’s a pleasure to work along side you. Keep up the good work!

[Brady Laughlin, MD @BradyationOnc]

I’m grateful to have worked with this team to collectively improve the training experience at Mayo Clinic programs! Here is our commentary regarding collective commitment across Graduate Medical Education: https://t.co/4oWW7IJpBd @AnnieSadostyMD @AaronBushMD

[Brady Laughlin, MD @BradyationOnc]

I’m excited to have been able to present the results of MC1635 at #ASTRO2023. MC1635 was a phase 3 trial evaluating MHF (moderate hypofractionation) 40 Gy in 15 fx vs. UHF (ultra-hypofractionation) 25 Gy in 5 fx WBI for early stage breast cancer following surgery

[Diego Toesca, MD @DiegoToesca]

@Dan_ChangMD Thank you, @Dan_ChangMD

[Diego Toesca, MD @DiegoToesca]

Honored for the opportunity to have presented the results of PCG GU002, a randomized, controlled, Ph 3 non-inf trial on SBPT vs. CFPT for low-risk PCa, and for receiving an ASTRO Travel Award!

https://t.co/OiQT9PKiet

[Mayo Clinic Arizona Radiation Oncology @MayoAZRadOnc]

Congratulations to our wonderful team on their efforts creating this video on the introduction to radiation therapy! Check the video here: https://t.co/TePWNVqbaf

@SameerKeoleMD @michelehalyard @ASTRO_org

[Mayo Clinic Arizona Radiation Oncology @MayoAZRadOnc]

We are proud to support our own Dr Sameer Keole, MD on his bid for ASTRO president! Thank you for your service and dedication to make our field better and brighter!! @SameerKeoleMD. Vote here: https://t.co/XcOGtHHtMU

[Prajnan Das, MD, MS, MPH @PrajnanDasMD]

Congrats to the authors of the PROSPECT trial! A tremendous accomplishment. #ASCO23 Some thoughts: